Matches in SemOpenAlex for { <https://semopenalex.org/work/W3145933000> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3145933000 endingPage "69" @default.
- W3145933000 startingPage "64" @default.
- W3145933000 abstract "Berberine(BBR) is an isoquinoline alkaloid extracted from Rhizoma coptidis and has been used for treating type 2 diabetes mellitus(T2DM) in China. The development of T2 DM is often associated with insulin resistance and impaired glucose uptake in peripheral tissues. In this study, we examined whether BBR attenuated glucose uptake dysfunction through the cholinergic anti-inflammatory pathway in Hep G2 cells. Cellular glucose uptake, quantified by the 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)-amino]-2-deoxy-D-glucose(2-NBDG), was inhibited by 21% after Hep G2 cells were incubated with insulin(10-6 mol/L) for 36 h. Meanwhile, the expression of alpha7 nicotinic acetylcholine receptor(α7n ACh R) protein was reduced without the change of acetylcholinesterase(ACh E) activity. The level of interleukin-6(IL-6) in the culture supernatant, the ratio of phosphorylated I-kappa-B kinase-β(IKKβ) Ser181/IKKβ and the expression of nuclear factor-kappa B(NF-κB) p65 protein were also increased. However, the treatment with BBR enhanced the glucose uptake, increased the expression of α7n ACh R protein and inhibited ACh E activity. These changes were also accompanied with the decrease of the ratio of p IKKβ Ser181/IKKβ, NF-κB p65 expression and IL-6 level. Taken together, these results suggest that BBR could enhance glucose uptake, and relieve insulin resistance and inflammation in Hep G2 cells. The mechanism may be related to the cholinergic anti-inflammatory pathway and the inhibition of ACh E activity." @default.
- W3145933000 created "2021-04-13" @default.
- W3145933000 creator A5009375833 @default.
- W3145933000 creator A5018436771 @default.
- W3145933000 creator A5049030137 @default.
- W3145933000 creator A5071640747 @default.
- W3145933000 creator A5072368992 @default.
- W3145933000 creator A5072788407 @default.
- W3145933000 date "2016-01-01" @default.
- W3145933000 modified "2023-09-23" @default.
- W3145933000 title "Berberine Relieves Insulin Resistance via the Cholinergic Anti-inflammatory Pathway in HepG2 Cells" @default.
- W3145933000 hasPublicationYear "2016" @default.
- W3145933000 type Work @default.
- W3145933000 sameAs 3145933000 @default.
- W3145933000 citedByCount "0" @default.
- W3145933000 crossrefType "journal-article" @default.
- W3145933000 hasAuthorship W3145933000A5009375833 @default.
- W3145933000 hasAuthorship W3145933000A5018436771 @default.
- W3145933000 hasAuthorship W3145933000A5049030137 @default.
- W3145933000 hasAuthorship W3145933000A5071640747 @default.
- W3145933000 hasAuthorship W3145933000A5072368992 @default.
- W3145933000 hasAuthorship W3145933000A5072788407 @default.
- W3145933000 hasConcept C100175707 @default.
- W3145933000 hasConcept C112446052 @default.
- W3145933000 hasConcept C126322002 @default.
- W3145933000 hasConcept C134018914 @default.
- W3145933000 hasConcept C185592680 @default.
- W3145933000 hasConcept C22885893 @default.
- W3145933000 hasConcept C2775910092 @default.
- W3145933000 hasConcept C2777391703 @default.
- W3145933000 hasConcept C2777730290 @default.
- W3145933000 hasConcept C2777866211 @default.
- W3145933000 hasConcept C2779306644 @default.
- W3145933000 hasConcept C2779730028 @default.
- W3145933000 hasConcept C2780116568 @default.
- W3145933000 hasConcept C55493867 @default.
- W3145933000 hasConcept C62478195 @default.
- W3145933000 hasConcept C71924100 @default.
- W3145933000 hasConcept C98274493 @default.
- W3145933000 hasConceptScore W3145933000C100175707 @default.
- W3145933000 hasConceptScore W3145933000C112446052 @default.
- W3145933000 hasConceptScore W3145933000C126322002 @default.
- W3145933000 hasConceptScore W3145933000C134018914 @default.
- W3145933000 hasConceptScore W3145933000C185592680 @default.
- W3145933000 hasConceptScore W3145933000C22885893 @default.
- W3145933000 hasConceptScore W3145933000C2775910092 @default.
- W3145933000 hasConceptScore W3145933000C2777391703 @default.
- W3145933000 hasConceptScore W3145933000C2777730290 @default.
- W3145933000 hasConceptScore W3145933000C2777866211 @default.
- W3145933000 hasConceptScore W3145933000C2779306644 @default.
- W3145933000 hasConceptScore W3145933000C2779730028 @default.
- W3145933000 hasConceptScore W3145933000C2780116568 @default.
- W3145933000 hasConceptScore W3145933000C55493867 @default.
- W3145933000 hasConceptScore W3145933000C62478195 @default.
- W3145933000 hasConceptScore W3145933000C71924100 @default.
- W3145933000 hasConceptScore W3145933000C98274493 @default.
- W3145933000 hasIssue "1" @default.
- W3145933000 hasLocation W31459330001 @default.
- W3145933000 hasOpenAccess W3145933000 @default.
- W3145933000 hasPrimaryLocation W31459330001 @default.
- W3145933000 hasRelatedWork W1968097192 @default.
- W3145933000 hasRelatedWork W1977381330 @default.
- W3145933000 hasRelatedWork W1981395870 @default.
- W3145933000 hasRelatedWork W2005392863 @default.
- W3145933000 hasRelatedWork W2007479353 @default.
- W3145933000 hasRelatedWork W2063714529 @default.
- W3145933000 hasRelatedWork W2077417063 @default.
- W3145933000 hasRelatedWork W2241763620 @default.
- W3145933000 hasRelatedWork W2257456590 @default.
- W3145933000 hasRelatedWork W2318680105 @default.
- W3145933000 hasRelatedWork W2342778169 @default.
- W3145933000 hasRelatedWork W2520731047 @default.
- W3145933000 hasRelatedWork W2766116407 @default.
- W3145933000 hasRelatedWork W2769002459 @default.
- W3145933000 hasRelatedWork W2790864824 @default.
- W3145933000 hasRelatedWork W2902276733 @default.
- W3145933000 hasRelatedWork W2999813679 @default.
- W3145933000 hasRelatedWork W3021138213 @default.
- W3145933000 hasRelatedWork W3045644757 @default.
- W3145933000 hasRelatedWork W3145866726 @default.
- W3145933000 isParatext "false" @default.
- W3145933000 isRetracted "false" @default.
- W3145933000 magId "3145933000" @default.
- W3145933000 workType "article" @default.